Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
Armata Pharmaceuticals Issues Letter to Shareholders – Oct 29, 2020
Biospace News
-
October 29, 2020
Lay off/Spin-off/Appointments
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Lay off/Spin-off/Appointments
Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer Nasdaq:CYCC
Lay off/Spin-off/Appointments
Catalent Boosts Supply Chain Transparency in Response to COVID-19 Manufacturing Urgency
Lay off/Spin-off/Appointments
First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca
Lay off/Spin-off/Appointments
Indus Holdings, Inc. Welcomes Bruce Gates to Board of Directors; Announces...
Globenewswire News
-
October 22, 2020
0
Lay off/Spin-off/Appointments
Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights...
Globenewswire News
-
October 22, 2020
0
Lay off/Spin-off/Appointments
Biopharma Money on the Move: October 15-21
Biospace News
-
October 22, 2020
0
Lay off/Spin-off/Appointments
BioSpace Global Roundup, Oct. 22
Biospace News
-
October 22, 2020
0
Lay off/Spin-off/Appointments
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Senior Corporate Executive...
Biospace News
-
October 22, 2020
0
1
2
3
...
53
Page 1 of 53
- Advertisement -
MOST POPULAR
Alexion to Report Second Quarter 2019 Results On Wednesday, July 24,...
July 10, 2019
Decipher Biosciences Announces Research Collaboration with Dendreon to Identify Genomic Drivers...
February 15, 2019
Pharmascience Inc. issues voluntary recall of Ranitidine Tablets 75mg, 150mg and...
October 24, 2019
Sarepta Exercises Option to Acquire Myonexus Therapeutics
February 28, 2019
Load more
HOT NEWS
Approval
Johnson & Johnson’s Balversa becomes first targeted therapy for metastatic bladder...
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Others
ASH19: Regeneron details first clinical data for bispecific antibody REGN5458 in...
Others
Roche and Spark Move Closer to Merger Following Endorsement from FTC...
